Back to Top Skip to main content

NHRC research protects U.S. military recruits from respiratory illness

Graphic from NHRC Public Affairs Graphic from NHRC Public Affairs

Recommended Content:

Research and Innovation | Adenovirus

KISSIMMEE, Fla. – Researchers from the Naval Health Research Center (NHRC) discussed ongoing surveillance for adenovirus, a contagious pathogen that causes respiratory illness, among U.S. military recruits during basic training at the Military Health System Research Symposium (MHRSRS), Aug. 27.

In the mid-1990s, the adenovirus vaccine was discontinued at military recruit training commands throughout the Department of Defense (DoD), resulting in frequent respiratory illness outbreaks. Adenovirus was the most prevalent and widely spread virus in military training environments, infecting up to 80 percent of recruits and resulting in lost training time and increased medical care. 

In 2011, the adenovirus vaccine was reinstated for military recruits after NHRC and the Walter Reed Army Institute of Research conducted a clinical trial that demonstrated its safety and efficacy. According to researchers with NHRC’s operational infectious diseases team, after the live, oral vaccine for adenovirus types 4 and 7 was resumed, rates of adenovirus among recruits declined dramatically—cases went from 250 each week to two, on average. To date, other adenovirus serotypes—3, 14, and 21—that had previously caused illness in recruits have not reemerged.  

Because there was such a dramatic drop in adenovirus-related cases, NHRC researchers wanted to determine if the vaccine provided protection against these other adenovirus serotypes that have not reemerged after vaccination reinstatement. Because the other serotypes were not detected by routine surveillance, they hypothesized the vaccine would provide similar coverage and induce immunity against the other non-vaccine serotypes. 

To test their hypothesis, researchers obtained 100 paired blood serum samples—samples obtained from recruits before and after they received the adenovirus vaccine—to test for changes in the level of antibodies found in the blood produced by the immune system to fight infection after vaccination. Using cell culture based serological microneutralization assays, researchers quantifiably measured antibody endpoint titers, a measure of the amount of antibodies in the blood stream that is believed to be correlative with the body’s immune response. 

Findings revealed that titers in the recruits’ blood before they were vaccinated were low against four of the five adenovirus types—4, 7, 14, and 21. The titers from the second sample, which were taken at least four weeks after the recruits were vaccinated, showed increased protection against the vaccine types 4 and 7, but not against the other three non-vaccine serotypes tested. Even though the vaccine protected against types 4 and 7, there was little evidence that it provided protection against the other adenovirus serotypes. 

Vaccination has dramatically decreased adenovirus-related illness and febrile respiratory rates in recruit population, resulting in less disruption and setbacks to training, reducing both the cost of health care and recruit training to the DoD. To understand why the other serotypes have not emerged among recruits after vaccination resumption and ensure recruits continue to be protected against outbreaks of this illness, researchers say further studies are needed. 

As the DoD’s premier deployment health research center, NHRC’s cutting-edge research and development is used to optimize the operational health and readiness of the nation’s armed forces. In proximity to more than 95,000 active duty service members, world-class universities, and industry partners, NHRC sets the standard in joint ventures, innovation, and translational research.

Disclaimer: Re-published content may have been edited for length and clarity. Read original post.

You also may be interested in...

Operational Infectious Diseases Weekly Update - 2018 Week 38

Publication
9/27/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 37

Publication
9/20/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 36

Publication
9/13/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 35

Publication
9/6/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 34

Publication
8/30/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Awards honor distinguished service, individual and team research

Article
8/21/2018
Pictured are the recipients of the 2018 MHSRS Awards, including the 2018 MHSRS Distinguished Service Award, the individual achievement in research awards, and the research team awards. Right to left are Air Force Maj. Joseph K. Maddry, Army Col. Michael P. Kozar, Kenneth M. Hargreaves, DDS, Ph.D., Navy Lt. Cmdr. Micah Gaspary, Australian Defence Force Col. Michael Reade, Army Col. Andrew P. Cap, Dr. Thomas Joiner and Dr. Peter Gutierrez. (MHS photo)

Three people, four teams recognized at symposium

Recommended Content:

MHSRS 2018 | Research and Innovation

Premier scientific symposium showcases medical research and development

Article
8/20/2018
Dr. Terry Adirim, deputy assistant secretary of defense for Health Services Policy and Oversight, speaks at a plenary session at the 2018 Military Health System Research Symposium, Aug. 20, at the Gaylord Palms Resort and Convention Center in Kissimmee, Florida. The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness: The Future Starts Now.” (MHSRS photo)

Recommended Content:

MHSRS 2018 | Research and Innovation

Researchers will present findings at Military Health System Research Symposium

Article
8/15/2018
The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness.”

As the DoD’s premier scientific meeting, MHSRS helps to facilitate the exchange of information between almost 3,000 attendees

Recommended Content:

MHSRS 2018 | Research and Innovation

Medical research and development take center stage at symposium

Article
8/15/2018
The theme of this year’s meeting is “Medical Innovation for Warfighter Readiness.”

Premier scientific meeting to draw 3,000 attendees

Recommended Content:

MHSRS 2018 | Research and Innovation

Operational Infectious Diseases Weekly Update - 2018 Week 31

Publication
8/13/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 30

Publication
8/3/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 28

Publication
7/20/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 23

Publication
6/13/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 22

Publication
6/7/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Influenza Seasonal | Adenovirus | Accession Screening and Immunization Program

Operational Infectious Diseases Weekly Update - 2018 Week 21

Publication
5/31/2018

A one-page weekly snapshot of current febrile respiratory illness and acute gastroenteritis surveillance at select DoD sites, meant to centralize all Naval Health Research Center surveillance work into one, user-friendly report.

Recommended Content:

Adenovirus | Influenza Seasonal | Accession Screening and Immunization Program
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 15

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing.. Download a PDF Reader or learn more about PDFs.